OncoResponse

0 followers


OncoResponse leverages the power of the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of antibody-derived therapeutics for the treatment of cancer.

Industries

Employees

11-50

Links


Org chart

Clifford J. Stocks
Chief Executive Officer
Collapse
Chris Russell
Chief Financial Officer
Kamal D. Puri
Chief Scientific Officer

Board & advisors